Metrics to compare | OBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.3x | −2.9x | −0.4x | |
PEG Ratio | −0.49 | 0.01 | 0.00 | |
Price/Book | 36.6x | 1.7x | 2.6x | |
Price / LTM Sales | 48.2x | 11.9x | 3.0x | |
Upside (Analyst Target) | - | 222.2% | 54.3% | |
Fair Value Upside | Unlock | −5.1% | 8.4% | Unlock |
Ondine Biomedical Inc., a life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally. Its primary product is Steriwave, a non-invasive, nurse-administered treatment that eliminates harmful bacteria, viruses, and fungi from the nose. In addition, the company offers a pipeline of photodisinfection products for various indications, including chronic sinusitis, ventilator-associated pneumonia, burns and other indications. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.